Investigation results: visual inspection: the product showed clearly signs of mould and slightly scratches on the housing.Additional are visible deposits in the outlet spout.Permeability test: the test showed that the m.Blue 10 is permeable.Computer controlled test: the computer controlled test has shown the opening pressure of the m.Blue 10, at a reference flow rate of 20 ml/hr in a horizontal position, to be 8.37 cmh2o.This is within the specified tolerance of 10 cmh2o ± 3 cmh2o.Additionally, the m.Blue 10 was tested according to standard procedure in the vertical position.At an opening pressure of 8 cmh2o in the vertical position, a pressure of 15 cmh2o ± 9 cmh2o is expected.The results indicated that at a reference flow of 20 ml/hr in the vertical position, the m.Blue 10 had a pressure of 10.14 cmh2o.This is within the specified tolerance of 15 cmh2o ± 9 cmh2o.Adjustability test: the m.Blue 10 was found to be adjustable to all pressure settings.Braking force and brake function test: the braking force of the m.Blue 10 ® was within the specified tolerance and the brake function operated as expected.Internal inspection of product: after dismantling of the valve, some deposits were found in m.Blue 10.Results: based on our investigation, we are not able to substantiate the claim of "non- adjustability" or "blockage".However, we assume that the significant deposits found within the valve may have temporarily caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke (b)(4).From our point of view, no further regulatory actions are required.
|